SCHEMBL31455417

SCHEMBL31455417

CC(C)(C)OC(=O)Nc1ccc(Nc2nc(-n3cccn3)ccc2[N+](=O)[O-])cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 1/20 0.39
MEN1 O00255 8/20 0.38
KMT2A Q03164 8/20 0.38
MAPT P10636 8/20 0.38
ALDH1A1 P00352 7/20 0.38
KDM4E B2RXH2 3/20 0.37
RXFP1 Q9HBX9 1/20 0.37
SYK P43405 1/20 0.37
LMNA P02545 3/20 0.37
RAB9A P51151 3/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
MCL1 Q07820 1/20 0.36
PTK2B Q14289 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
MDM2 Q00987 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31455273 0.82 NPC1 (0.40) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL31455428 0.82 FGFR4 (0.44) PRMT1MEN1KMT2AMAPTRAB9A
SCHEMBL31455563 0.81 PRMT1 (0.43) PRMT1MEN1KMT2AMAPTALDH1A1
SCHEMBL31455251 0.81 PRMT1 (0.43) PRMT1MEN1KMT2AMAPTSYK
SCHEMBL31455392 0.80 PORCN (0.41) PRMT1MEN1KMT2AMAPTLMNA
SCHEMBL31420343 0.80 PRMT1 (0.41) PRMT1MEN1KMT2AMAPTKDM4E
SCHEMBL31455818 0.79 PRMT1 (0.41) PRMT1MEN1KMT2AMAPTALDH1A1
SCHEMBL31455292 0.79 PRMT1 (0.41) PRMT1MEN1KMT2AMAPTALDH1A1
SCHEMBL31371442 0.78 SYK (0.39) PRMT1MEN1KMT2AMAPTALDH1A1
SCHEMBL31455353 0.78 MAPT (0.38) MEN1KMT2AMAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059577-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed